Rationale of the growth failure in children with renal diseases study
Open Access
- 28 February 1990
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 116 (2) , S11-S16
- https://doi.org/10.1016/s0022-3476(05)82917-8
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Growth assessment in abnormal childrenKidney International, 1978
- Energy balance and growth: Experience in treating children with malnutritionKidney International, 1978
- DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROLThe Lancet, 1978
- Abnormal Carbohydrate Metabolism in Chronic Renal FailureJournal of Clinical Investigation, 1978
- Effectiveness of 1 α-hydroxyvitamin D3 in children with renal osteodystrophy associated with hemodialysisThe Journal of Pediatrics, 1977
- Iatrogenic magnesium intoxication during 1-alpha-hydroxycholecalciferol treatment.BMJ, 1976
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- Plasma amino acids in children and adolescents on hemodialysisKidney International, 1976